Figure 3From: Randomised, double-blind, placebo-controlled trial of oral budesonide for prophylaxis of acute intestinal graft-versus-host disease after allogeneic stem cell transplantation (PROGAST) Cumulative incidence of death after prophylaxis with budesonid and placebo (p = 0.25). Back to article page